Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Cat, Human, Mouse, Pig|
|Host / Isotype||Rat / IgG1|
|Immunogen||Purified, recombinant mouse Fas ligand (residues 132-279).|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|ELISA (ELISA)||0.5-1.0 ug/ml|
|Inhibition Assays (IA)||10-20 ug/ml|
|Neutralization (Neu)||10-20 ug/ml|
|Western Blot (WB)||0.1-0.2 ug/ml|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
MA1-24729 detects Fas Ligand from mouse samples. MA1-24729 is expected to cross react with human (100% conserved), feline (89% conserved), and porcine (88% conserved) due to sequence homology.
MA1-24729 has been successfully used in neutralization, inhibition assays, and Western blot procedures. The Neutralization Dose50 (ND50) for Monoclonal Anti-Mouse Fas Ligand is approximately 10-20 ug/ml.
The MA1-24729 immunogen is purified, recombinant mouse Fas ligand (residues 132-279).
Fas ligand (FasL, CD 95L) is a type-II-membrane protein, whose N-terminus is in the cytoplasm and its C-terminal region extends into the extracellular space. Its receptor Fas (CD 95, Apo-1) is a cell-surface-type-I-membrane protein and a member of the tumor necrosis factor (TNF) and nerve growth factor (NGF) receptor family.
As a member of the TNF-cytokine family FasL induces apoptosis when interacting with its receptor Fas. FasL may exist as either membrane bound (45 kD) or soluble forms (26 kD).
The soluble protein can be released from cells upon cleavage by metalloproteinases. Binding of FasL to Fas leads to oligomerization of the receptor and triggers apoptotic cell death through the interaction of other proteins.
FasL is predominantly expressed in activated T-lymphocytes and natural killer (NK) cells also it is expressed in the tissues of immune-privilege sites such as testis and eye. FasL expression is also reported in various tissues as thymus, liver, ovary, lung, heart and kidney.
The Fas/FasL system has been shown to play a role in a number of human diseases, for example AIDS, hepatitis or cancer. It is assumed that induction of apoptosis through FasL is predominantly involved in anti-viral immune responses.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
APO1; apoptosis (APO-1) antigen ligand 1; apoptosis antigen ligand; apoptosis antigen ligand 1; CD178; CD95 ligand; CD95L; Fas antigen ligand; Fas Ligand; Fas ligand (TNF superfamily, member 6); Fas-LG; FasL; generalized lymphoproliferative disease; mutant tumor necrosis factor family member 6; tumor necrosis factor (ligand) superfamily, member 6; tumor necrosis factor ligand 1A; tumor necrosis factor ligand superfamily member 6
ALPS1B; APT1LG1; APTL; CD178; CD95-L; CD95L; Fas-L; FASL; FASLG; gld; TNFSF6; TNLG1A